Magyar Dermatológiai Társulat IMmune-related Pathologies: Understanding Leukocyte Signaling and Emerging therapies - IMPULSE 2013
Rendezvény kezdete: 2013.08.31.Rendezvény vége: 2013.09.03. Helyszín: Mátraháza, Residence Ózon**** Conference & Wellness Hotel A rendezvény Web oldala: http://www.impulse.org.hu/venue-and-accommodation.html The subject of the 2013 IMPULSE symposium will be
"Molecular mechanisms and therapeutic targets in inflammation".
The meeting will bring together basic scientists, clinicians and representatives of the pharmaceutical industry to discuss the understanding and therapy of inflammatory diseases.
IMPULSE 2013 will focus on the following topics:
B cells as therapeutic targets
Therapeutic targeting of T cells
Ion channels and inflammation
Therapeutic targets in inflammation
Microvesicles & Inflammation/Disease
Development and application of therapeutic antibodies in inflammatory diseases
Participants with academic, clinical and industrial relations are kindly invited to create this melting pot: IMPULSE
Magyar Immunológiai Társaság IMPULSE Szimpózium (Mátraháza, 2013.08.31-09.03.)
Rendezvény kezdete: 2013.08.31.Rendezvény vége: 2013.09.03. Tudományos információ: Anna ERDEI, Gabriella SÁRMAY, Imre KACSKOVICS, János MATKÓ, Attila MÓCSAI, György PANYI, József PRECHL Címe: www.impulse.org.hu E-mail: impulse@impulse.org.hu Munkahely neve: Arts and Graphs (Conference Secreteriat) E-mail: impulse@impulse.org.hu Helyszín: Mátraháza, A rendezvény Web oldala: http://www.impulse.org.hu IMPULSE: IMmune-related Pathologies: Understanding Leukocyte Signaling and Emerging therapies - IMPULSE 2013, an EFIS-EJI Symposium
Deadline for submission of abstracts: July 1, 2013
Early registration: June 15, 2013
Further information is available on the website.
EFIS bursaries (covering registration fee and full accomodation) for talented scientist under 35 are still available. Applicants have to send their abstract and CV to matko@elte.hu and cc to anna.erdei@freemail.hu
Make sure to submit your abstract in time and don't forget to apply for an EFIS bursary if you are under 35!
SCIENTIFIC PROGRAM
Molecular mechanisms and therapeutic targets in inflammation
MAJOR TOPICS:
-B cells
-T cells
-Ion channels and inflammation
-Therapeutic targets in inflammation
-Microvesicles & Inflammation or Disease
-Development and application of therapeutic antibodies in inflammatory diseases Kapcsolódó dokumentumok (2)
Magyar Endokrinológiai és Anyagcsere Társaság The Athens PCOS International Congress
Rendezvény kezdete: 2006.03.27.Rendezvény vége: 2006.03.29. Tudományos információ: Prof. Dimitrios Panidis & Associate Prof. Evanthia Diamanti-Kandarakis Munkahely neve: Erasmus Conferences Tours & Travel S.A. Címe: 1, Kolofontos & Evridikis str., 161 21 Athens – Greece Tel: +30 210 7257693 Fax: +30 210 7257532 E-mail: info@pcos2006.com Helyszín: Grande Bretagne Hotel, Athens, Greece A rendezvény Web oldala: http://www.pcos2006.com/ This multifaceted and pluripotential syndrome, since it has been described - 50 years ago – continues to attract the interest of a steadily increasing number of physicians and scientists covering the whole spectrum of subspecialties in medicine (Endocrinologists, Gynaecologists, Cardiologists, Dermatologists). This Meeting is hosted by the Hellenic Society of Endocrinology, and jointly organized with the Department of Endocrinology of Medical School of University of Athens, the Medical School of University of Thessaloniki and the Androgen Excess Society.
Magyar Immunológiai Társaság 8th Translational Immunology School
Rendezvény kezdete: 2019.04.11.Rendezvény vége: 2019.04.13. Helyszín: Germany, Potsdam, A rendezvény Web oldala: https://dgfi.org/akademie-fuer-immunologie/translational-school/ The School
The Translational Immunology Schools (TIS) up to now were great success stories. They were attended each by more than 50 people from academic research as well as from clinical research institutions and industry. The topics covered include developments in diagnostics, new research technologies, modern immune intervention and new immune therapeutic principles. Moreover there was a focus on vaccines and B cells as important therapeutic targets. Furthermore, we discussed the current status on stem cell therapy, gene therapy and immune therapy of tumors as well as transplantation tolerance in the last translational schools. Similar topics will be presented on our 8th Translational Immunology School. Since 2014 various changes were introduced for the school: